全文获取类型
收费全文 | 199篇 |
免费 | 11篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 2篇 |
妇产科学 | 1篇 |
基础医学 | 9篇 |
口腔科学 | 55篇 |
临床医学 | 8篇 |
内科学 | 58篇 |
皮肤病学 | 1篇 |
神经病学 | 4篇 |
特种医学 | 3篇 |
外科学 | 16篇 |
预防医学 | 3篇 |
眼科学 | 4篇 |
药学 | 38篇 |
肿瘤学 | 6篇 |
出版年
2023年 | 2篇 |
2022年 | 1篇 |
2021年 | 12篇 |
2020年 | 2篇 |
2019年 | 8篇 |
2018年 | 4篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 3篇 |
2014年 | 6篇 |
2013年 | 14篇 |
2012年 | 17篇 |
2011年 | 11篇 |
2010年 | 9篇 |
2009年 | 8篇 |
2008年 | 6篇 |
2007年 | 7篇 |
2006年 | 9篇 |
2005年 | 4篇 |
2004年 | 9篇 |
2003年 | 5篇 |
2002年 | 2篇 |
2001年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 5篇 |
1970年 | 1篇 |
1969年 | 3篇 |
1968年 | 3篇 |
1967年 | 1篇 |
1966年 | 2篇 |
1965年 | 1篇 |
排序方式: 共有210条查询结果,搜索用时 627 毫秒
21.
Microfluidics for cell separation 总被引:2,自引:0,他引:2
Ali Asgar S. Bhagat Hansen Bow Han Wei Hou Swee Jin Tan Jongyoon Han Chwee Teck Lim 《Medical & biological engineering & computing》2010,48(10):999-1014
The need for efficient cell separation, an essential preparatory step in many biological and medical assays, has led to the recent development of numerous microscale separation techniques. This review describes the current state-of-the-art in microfluidics-based cell separation techniques. Microfluidics-based sorting offers numerous advantages, including reducing sample volumes, faster sample processing, high sensitivity and spatial resolution, low device cost, and increased portability. The techniques presented are broadly classified as being active or passive depending on the operating principles. The various separation principles are explained in detail along with popular examples demonstrating their application toward cell separation. Common separation metrics, including separation markers, resolution, efficiency, and throughput, of these techniques are discussed. Developing efficient microscale separation methods that offering greater control over cell population distribution will be important in realizing true point-of-care (POC) lab-on-a-chip (LOC) systems. 相似文献
22.
23.
Duraisamy Kempuraj Mohammad Moshahid Khan Ramasamy Thangavel Zhi Xiong Evert Yang Asgar Zaheer 《Journal of neuroimmune pharmacology》2013,8(3):643-650
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Multiple sclerosis (MS) involve activation of glial cells and release of inflammatory mediators leading to death of neurons. Glia maturation factor (GMF) is up-regulated in the central nervous system (CNS) in these neurodegenerative diseases. Interleukin-33 (IL-33) is highly expressed constitutively in the CNS. We have treated mouse astrocytes, mixed culture with glial cells and neurons, and only neurons with GMF and/or IL-33 in vitro. Both GMF and IL-33-induced chemokine (C-C motif) ligand 2 (CCL2) release in a dose and time-dependent manner. We report that GMF induced IL-33 release, and that IL-33 augments GMF-induced tumor necrosis factor-alpha (TNF-α) release from mouse astrocytes. IL-33 induces CCL2, TNF-α and nitric oxide release through phosphorylation of ERK in mouse astrocytes. Incubation of mixed culture containing glial cells and neurons or only neuronal culture with IL-33 reduced the number of neurons positive for microtubule-associated protein 2. In conclusion, IL-33 augments GMF-mediated neuroinflammation and may provide a new drug target for neurodegenerative and autoimmune diseases. 相似文献
24.
Ashu Mittal Udaivir S. Sara Asgar Ali Aqil Mohammed 《Pharmaceutical development and technology》2013,18(4):422-434
The matrix type transdermal drug delivery systems (patches) of Nitrendipine were prepared by film casting technique. The patches were characterized for physical, in vitro release studies and ex-vivo permeation studies (human cadaver skin). On the basis of in vitro drug release and skin permeation performance, formulation B3 was found to be better than the other formulations and it was selected as the optimized formulation. The final optimized formulation (B3) was subjected to skin irritation, pharmacokinetic, pharmacodynamic and stability studies. The maximum percentage drug release in 48 hours was 94.67 ± 3.25 for B3 and 91.43 ± 2.106 for A2 formulation. Again formulation B3 (0.0627 mg/cm2/h) and A2 (0.0566 mg/cm2/h) showed maximum skin flux in the respective series. Patches prepared with Plasdone S-630 were more flexible as compared to PVP K 30 containing patches. Patches prepared with PVP K 30 showed drug release and skin permeation at higher percentage as compared to those containing Plasdone S-630. The interaction studies carried out by comparing the results of ultraviolet, infrared, TLC and DSC analyses for the pure drug, medicated and placebo formulations indicated no chemical interaction between the drug and excipients. The TDDS was found to be free of any skin irritation as suggested by skin irritation score of 1.16 (< 2.00) under Draize score test. 相似文献
25.
Dmitriy N. Feldman MD Herbert D. Aronow MD MPH Rajesh V. Swaminathan MD J. Dawn Abbott MD Jennifer A. Tremmel MD MS Navin K. Kapur MD John P. Breinholt MD Anita W. Asgar MD Duane S. Pinto MD MPH Thomas M. Tu MD Kenneth M. Rosenfield MD Srihari S. Naidu MD 《Catheterization and cardiovascular interventions》2016,88(5):674-677
26.
Anita W. Asgar Maral Ouzounian Corey Adams Jonathan Afilalo Stephen Fremes Sandra Lauck Jonathan Leipsic Nico Piazza Josep Rodes-Cabau Robert Welsh Harindra C. Wijeysundera John G. Webb 《The Canadian journal of cardiology》2019,35(11):1437-1448
Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care for patients believed to be inoperable or at high surgical risk, and a reasonable alternative to surgical aortic valve replacement for those at intermediate surgical risk. Recent clinical trial data have shown the benefits of this technology in patients at low surgical risk as well. This update of the 2012 Canadian Cardiovascular Society TAVI position statement incorporates clinical evidence to provide a practical framework for patient selection that does not rely on surgical risk scores but rather on individual patient evaluation of risk and benefit from either TAVI or surgical aortic valve replacement. In addition, this statement features new wait time categories and treatment time goals for patients accepted for TAVI. Institutional requirements and recommendations for operator training and maintenance of competency have also been revised to reflect current standards. Procedural considerations such as decision-making for concomitant coronary intervention, antiplatelet therapy after intervention, and follow-up guidelines are also discussed. Finally, we suggest that all patients with aortic stenosis might benefit from evaluation by the heart team to determine the optimal individualized treatment decision. 相似文献
27.
Upfront problems about the use of synthetic insecticides such as damage to the environment and human health and pests’ resistance have brought about interest in natural compounds. In the last few years, more studies have been published for the insecticidal effects of essential oils from several plant families such as Apiaceae, Asteraceae, Cupressaceae, Lamiaceae, Lauraceae, Myrtaceae, Poaceae, Piperaceae, Rutaceae and Zingiberaceae. The present article emphases on the effects of essential oils against Coleopteran insect pests by highlighting on their extraction, chemical insecticidal properties, mode of action on insect, commercialization and safety. 相似文献
28.
Characterization of the pore structure of compacted and sintered parts made from a nickel-base powder was accomplished using the mercury porosimetry method. The theoretical density values for the sintered specimens varied from 56.3 to 96.7% which corresponds to a porosity of 43.7 to 3.3%. A maximum interconnecting median pore diameter of 21 mum resulted from a -80/+200 mesh powder compacted at 138 MN/m2 and sintered for 2 h at 1250 degrees C. Photomicrographs of the same sample showed that it had a maximum pore diameter of 200 mum. The interconnected pore volume decreased with decreasing particle size of the powder, increasing compaction pressure, and increasing sintering temperature. Mechanical properties of tensile strength, yield strength, elastic modulus and percentage elongation were correlated with the pore structure. Proper selection of particle size, compaction pressure, sintering times and sintering temperatures should permit parts with controlled porosity characteristics to be produced that possess adequate mechanical properties for application as implants. 相似文献
29.
Ali Asgar Attarwala Yvonne Wanjiku Karanja Deni Hardiansyah Chiara Romanó Mareike Roscher Björn Wängler Gerhard Glatting 《Zeitschrift für medizinische Physik》2017,27(2):132-144
Aim
In this study the performance characteristics of the Albira II PET sub-system and the response of the system for the following radionuclides 18F, 68Ga and 64Cu was analyzed.Materials and methods
The Albira II tri-modal system (Bruker BioSpin MRI GmbH, Ettlingen, Germany) is a pre-clinical device for PET, SPECT and CT. The PET sub-system uses single continuous crystal detectors of lutetium yttrium orthosilicate (LYSO). The detector assembly consists of three rings of 8 detector modules. The transaxial field of view (FOV) has a diameter of 80 mm and the axial FOV is 148 mm. A NEMA NU-4 image quality phantom (Data Spectrum Corporation, Durham, USA) having five rods with diameters of 1, 2, 3, 4 and 5 mm and a uniform central region was used. Measurements with 18F, 68Ga and 64Cu were performed in list mode acquisition over 10 h. Data were reconstructed using a maximum-likelihood expectation-maximization (MLEM) algorithm with iteration numbers between 5 and 50. System sensitivity, count rate linearity, convergence and recovery coefficients were analyzed.Results
The sensitivities for the entire FOV (non-NEMA method) for 18F, 68Ga and 64Cu were (3.78 ± 0.05)%, (3.97 ± 0.18)% and (3.79 ± 0.37)%, respectively. The sensitivity based on the NEMA protocol using the 22Na point source yielded (5.53 ± 0.06)%. Dead-time corrected true counts were linear for activities ≤7 MBq (18F and 68Ga) and ≤17 MBq (64Cu) in the phantom. The radial, tangential and axial full widths at half maximum (FWHMs) were 1.52, 1.47 and 1.48 mm. Recovery coefficients for the uniform region with a total activity of 8 MBq in the phantom were (0.97 ± 0.05), (0.98 ± 0.06), (0.98 ± 0.06) for 18F, 68Ga and 64Cu, respectively.Conclusion
The Albira II pre-clinical PET system has an adequate sensitivity range and the system linearity is suitable for the range of activities used for pre-clinical imaging. Overall, the system showed a favorable image quality for pre-clinical applications. 相似文献30.
Iqbal Ahmad Mohammed Anwar Sohail Akhter Pallavi Thakur Raman Chawla Rakesh Kumar Sharma Asgar Ali Farhan Jalees Ahmad 《Journal of pharmaceutical innovation》2016,11(4):308-322